| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |